{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:31:41Z","timestamp":1788827501366,"version":"build-2803163510"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010870","name":"Qingdao Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["20-3-4-54-nsh"],"award-info":[{"award-number":["20-3-4-54-nsh"]}],"id":[{"id":"10.13039\/501100010870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,12,22]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The impact of serum uric acid (sUA) levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome (ACS) and hypertension after percutaneous coronary intervention (PCI) is not fully clear. This study aimed to assess the association among sUA levels, clinical prognosis and severity of coronary artery disease in patients with ACS and hypertension after PCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>In this prospective cohort study, we followed-up patients with ACS and hypertension after PCI for 1 year to explore the risk factors for 1 year total major adverse cardiovascular events (MACEs) and multivessel coronary artery disease, the dose-effect relationship among sUA levels, MACEs and severity of coronary artery disease and correlation between sUA levels and severity of coronary artery disease (Gensini score).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting\/patients<\/jats:title>\n                    <jats:p>Several Chinese internists followed-up 422 patients who were diagnosed with ACS and hypertension after PCI in a large tertiary hospital of Qingdao during the period from 1 June 2019 to 1 December 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>One-year follow-up MACEs results and coronary angiography results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the coronary angiography results, multivessel coronary artery disease (28.5% vs 21.4%, p=0.006) and non-culprit lesion vascular occlusion (11.7% vs 5.3%, p=0.042) were more common in the hyperuricaemia group, and the Gensini score (26.69\u00b113.46 vs 17.66\u00b110.57, p&lt;0.001) was also higher. In the results of 1-year MACEs, the incidence of all-cause mortality (3.5% vs 2.5%, p=0.037), PCI or coronary artery bypass grafting therapy due to myocardial infarction or angina pectoris (15.1% vs 7.6%, p=0.027), medication conservative therapy in hospital due to myocardial infarction or angina pectoris (12.9% vs 6.7%, p=0.041) and total MACEs (31.8% vs 16.9%, p=0.001) were higher in patients with hyperuricaemia. Univariate and multivariate logistic regression analysis models showed that hyperuricaemia was still an independent risk factor for total MACEs within 1 year (OR=2.618, 95% CI 1.656 to 4.139, p&lt;0.001; OR=1.920, 95% CI 1.158 to 3.183, p=0.011, respectively) and multivessel coronary artery disease (OR=2.140, 95% CI 1.371 to 3.342, p=0.001; OR=1.688, 95% CI 1.051 to 2.710, p=0.030, respectively) after adjusting for confounding factors. The severity of coronary artery disease (non-culprit lesion vascular occlusion (4.7% vs 8.4% vs 9.6% vs 16.2%, p=0.041); multivessel coronary artery disease (17.9% vs 22.4% vs 29.8% vs 35.2%, p=0.022); Gensini score (16.96\u00b110.35 vs 19.31\u00b110.63 vs 26.12\u00b111.48 vs 33.33\u00b114.01, p&lt;0.001)) and the incidence of total MACEs (13.2% vs 14.2% vs 34.6% vs 41%, p&lt;0.001) increased significantly with the sUA levels increasing. Further, the Gensini score was positively correlated with uric acid levels (r=0.515, p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hyperuricaemia is an independent risk factor for 1-year total MACEs and multivessel coronary artery disease in patients with ACS and hypertension after PCI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-052031","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T11:50:19Z","timestamp":1641988219000},"page":"e052031","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8802-1249","authenticated-orcid":false,"given":"Shiyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Song","sequence":"additional","affiliation":[{"name":"Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichu","family":"Yu","sequence":"additional","affiliation":[{"name":"Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, shandong, China"},{"name":"Cardiology, The Affiliated Cardiovascular Hospital of Qingdao University, qingdao, shandong, china"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiology, Jiaozhou Branch of Shanghai East Hospital,Tongji University, qingdao, shandong, china"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Shao","sequence":"additional","affiliation":[{"name":"Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"2025121605221957000_12.1.e052031.1","doi-asserted-by":"crossref","unstructured":"Metkus T . Incidence, predictors and prognosis of respiratory support in non-ST segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 2020.","DOI":"10.1177\/2048872620919947"},{"key":"2025121605221957000_12.1.e052031.2","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13074","article-title":"Prognostic value of hyperuricemia in patients with acute coronary syndrome: a meta-analysis","volume":"49","author":"He","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"2025121605221957000_12.1.e052031.3","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"2025121605221957000_12.1.e052031.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"2025121605221957000_12.1.e052031.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0684-z"},{"key":"2025121605221957000_12.1.e052031.6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2016.07.026","article-title":"High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects","volume":"37","author":"Cicero","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2025121605221957000_12.1.e052031.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-019-1953-9","article-title":"Mediation of the effect of serum uric acid on the risk of developing hypertension: a population-based cohort study","volume":"17","author":"Cao","year":"2019","journal-title":"J Transl Med"},{"key":"2025121605221957000_12.1.e052031.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.08.086"},{"key":"2025121605221957000_12.1.e052031.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106130"},{"key":"2025121605221957000_12.1.e052031.10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.183244"},{"key":"2025121605221957000_12.1.e052031.11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/HJH.0000000000000478","article-title":"Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis","volume":"33","author":"Fan","year":"2015","journal-title":"J Hypertens"},{"key":"2025121605221957000_12.1.e052031.12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/HJH.0000000000001980","article-title":"Uric acid and hypertension: a focused review and practical recommendations","volume":"37","author":"De Becker","year":"2019","journal-title":"J Hypertens"},{"key":"2025121605221957000_12.1.e052031.13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jjcc.2020.12.013","article-title":"Uric acid and cardiovascular disease: a clinical review","volume":"78","author":"Saito","year":"2021","journal-title":"J Cardiol"},{"key":"2025121605221957000_12.1.e052031.14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.numecd.2021.01.023","article-title":"Uric acid in chronic coronary syndromes: relationship with coronary artery disease severity and left ventricular diastolic parameter","volume":"31","author":"Maloberti","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025121605221957000_12.1.e052031.15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-1-199907060-00003"},{"key":"2025121605221957000_12.1.e052031.16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1381612825666190408122557","article-title":"Hyperuricemia and cardiovascular disease","volume":"25","author":"Zhang","year":"2019","journal-title":"Curr Pharm Des"},{"key":"2025121605221957000_12.1.e052031.17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5114\/aoms.2019.84397","article-title":"Association of anti-hyperuricemia treatment and prevalent cardiovascular disease in hypertensive patients","volume":"16","author":"Zeng","year":"2020","journal-title":"Arch Med Sci"},{"key":"2025121605221957000_12.1.e052031.18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11302-018-9604-9","article-title":"Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome","volume":"14","author":"Gaubert","year":"2018","journal-title":"Purinergic Signal"},{"key":"2025121605221957000_12.1.e052031.19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2013.11.051","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies","volume":"232","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"2025121605221957000_12.1.e052031.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2010.00555.x"},{"key":"2025121605221957000_12.1.e052031.21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2020.01.025","article-title":"Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention","volume":"297","author":"Lim","year":"2020","journal-title":"Atherosclerosis"},{"key":"2025121605221957000_12.1.e052031.22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40292-020-00368-z","article-title":"Hyperuricemia and risk of cardiovascular outcomes: the experience of the URRAH (uric acid right for heart health) project","volume":"27","author":"Maloberti","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2025121605221957000_12.1.e052031.23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020 International Society of hypertension global hypertension practice guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"J Hypertens"},{"key":"2025121605221957000_12.1.e052031.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000134"},{"key":"2025121605221957000_12.1.e052031.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(83)80105-2"},{"key":"2025121605221957000_12.1.e052031.26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VHRM.S115080","article-title":"An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia","volume":"13","author":"Bove","year":"2017","journal-title":"Vasc Health Risk Manag"},{"key":"2025121605221957000_12.1.e052031.27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06531"},{"key":"2025121605221957000_12.1.e052031.28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","article-title":"Uric acid and cardiovascular disease","volume":"484","author":"Ndrepepa","year":"2018","journal-title":"Clin Chim Acta"},{"key":"2025121605221957000_12.1.e052031.29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2016.2491","article-title":"Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: a mechanism for uric acid-induced endothelial dysfunction","volume":"37","author":"Li","year":"2016","journal-title":"Int J Mol Med"},{"key":"2025121605221957000_12.1.e052031.30","first-page":"1","article-title":"Uric acid induces endothelial dysfunction by activating the HMGB1\/RAGE signaling pathway","volume":"2017","author":"Cai","year":"2017","journal-title":"Biomed Res Int"},{"key":"2025121605221957000_12.1.e052031.31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2020.07.013","article-title":"Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome","volume":"82","author":"Centola","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2025121605221957000_12.1.e052031.32","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2009.50.559"},{"key":"2025121605221957000_12.1.e052031.33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3325\/cmj.2012.53.162","article-title":"On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies","volume":"53","author":"Trkulja","year":"2012","journal-title":"Croat Med J"},{"key":"2025121605221957000_12.1.e052031.34","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct083"},{"key":"2025121605221957000_12.1.e052031.35","first-page":"1","article-title":"Hyperuricemia is a risk factor for one-year overall survival in elderly female patients with acute coronary syndrome","volume":"2020","author":"Tai","year":"2020","journal-title":"Cardiovasc Ther"},{"key":"2025121605221957000_12.1.e052031.36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00059-019-04849-3","article-title":"Prognostic value of serum uric acid levels in patients with non-STEMI undergoing percutaneous coronary intervention","volume":"45","author":"\u00c7anga","year":"2020","journal-title":"Herz"},{"key":"2025121605221957000_12.1.e052031.37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9731374","article-title":"Baseline serum uric acid levels are associated with all-cause mortality in acute coronary syndrome patients after percutaneous coronary intervention","volume":"2018","author":"Ye","year":"2018","journal-title":"Dis Markers"},{"key":"2025121605221957000_12.1.e052031.38","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.124"},{"key":"2025121605221957000_12.1.e052031.39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0035-1569405","article-title":"Effects of uric acid on the NO production of HUVECs and its restoration by urate lowering agents","volume":"66","author":"Mishima","year":"2016","journal-title":"Drug Res"},{"key":"2025121605221957000_12.1.e052031.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.08.054"},{"key":"2025121605221957000_12.1.e052031.41","first-page":"29","article-title":"Association between serum uric acid level with presence and severity of coronary artery disease","volume":"67","author":"Kumbhalkar","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"2025121605221957000_12.1.e052031.42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3760\/cma.j.issn.0366-6999.20133024","article-title":"Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease","volume":"127","author":"Yu","year":"2014","journal-title":"Chin Med J"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-052031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:22:35Z","timestamp":1765891355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-052031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,12]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjopen-2021-052031"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-052031","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}